|
Pharmaceutical
SeekingAlpha.com: Home Page:
Zacks.com submits: Recently, Bristol-Myers Squibb Co. (BMY) received approval from the U.S. Food and Drug Administration (FDA) to market Abilify (aripiprazole) for the treatment of irritability in pediatric patients having au (Read More)
Wall Street Journal:
Enter Bidder No. 3: Nestle? Bloomberg is reporting that the Swiss food, beverage and pharmaceutical conglomerate is exploring the possibility of making a run for U.K. chocolate maker Cadbury.But before investors bet that Nest (Read More)
Wall Street Journal:
BOSTON (MarketWatch) -- Drug stocks advanced substantially in early action Monday, echoing gains in the broader market, while shares of Cephalon Inc. fell on news that a later-stage clinical study for its pediatric drug Cinq (Read More)
guardian.co.uk Society:
Flibanserin's makers promise help for 'hypoactive sexual desire disorder'. It suit drug companies to medicalise in this wayBefore everyone jumps on the hype bandwagon by calling flibanserin a drug recently announced as a solu (Read More)
The Guardian:
ITV on course to beat already-upgraded ad revenue forecast by at least £10m, after sales market 'goes ballistic'ITV is on target for a bumper December, with advertising revenue expected to be up 12% year on year for ITV1 and (Read More)
www.guardian.co.uk:
Developing nations call for UN body to police battle on climate changeA green technology body with powers to direct a worldwide transition away from a high-carbon economy is needed to combat climate change, according to the w (Read More)
Pharma Marketing Blog:
Now that the big FDA public hearing is over, many people are asking "What's the next steps?" If you are like me, you expect FDA to issue new guidance. My friend John Murray has outlined the usual process FDA goes through when (Read More)
News Networks:
Advertising & Marketing,
Competitive Intelligence
guardian.co.uk Society:
The pharmaceutical industry has taken almost two years to disseminate important informationOnce your medicines regulator decides it should change the side-effect warnings contained in the patient information of a drug taken b (Read More)
PharmaTimes World News:
Otsuka Pharmaceutical has pulled an application in Europe to get an extension on the label for its big-selling antipsychotic Abilify, partnered elsewhere with Bristol-Myers Squibb. (Read More)
News Network:
Pharmaceutical
Huffington Post:
WASHINGTON — They call it the "Botax." The White House and Senate Democrats have turned to a proposal to tax breast implants, tummy tucks, wrinkle-smoothing injections and other procedures as they search for ways to pay for c (Read More)
Wall Street Journal:
BOSTON (MarketWatch) -- Drug stocks clung to the flat line early Friday as shares of Poniard Pharmaceuticals slid for the second day. The NYSE Arca Pharmaceutical Index was down marginally at 301.14 while the NYSE Arca Biot (Read More)
Wall Street Journal:
MADRID (MarketWatch) -- German pharmaceutical and chemical company Merck KGaA was downgraded to hold from buy on Friday at Citigroup, which said the risk-reward looks evenly balanced. The rejection of Erbitux by the Committe (Read More)
India Times:
Indian pharmaceutical market, which has registered robust growth in last few years, was valued at over Rs 55,000 crore in the last fiscal, the Lok Sabha was informed today. (Read More)
The Economist:
The search continues for a pill that will lift a woman’s libidoBACK in the 1990s a drug firm called Pfizer thought it had a treatment for angina. Unfortunately, the new medicine failed its clinical trials. But a curious side- (Read More)
The Economist:
Toyota spent the most on research and development (R&D) of any company in the world in 2008, according to the European Commission’s latest tally. The Japanese carmaker increased its annual R&D spending by 7.6% to €7.6 billion (Read More)
Wall Street Journal:
Allergan and Medicis Pharmaceutical Corp. lead drug stocks lower in morning activity as shares of the dermatology-products makers fall on news that the health-care reform bill put forth by Senate Democrats would levy a 5% tax (Read More)
Wall Street Journal:
BOSTON (MarketWatch) -- Allergan Inc. and Medicis Pharmaceutical Corp. led drug stocks lower early Thursday as shares of the dermatology-products makers fell on news that a new bill unveiled by Senate Democrats would levy a (Read More)
Wall Street Journal:
German pharmaceutical and chemical company Bayer said it will appeal a decision by the U.K.'s health-care cost regulator not to recommend the company's Nexavar for liver cancer treatment. (Read More)
Wall Street Journal:
The world's top largest pharmaceutical firm is reported planning to release generic drugs in Japan as early as 2011, expecting demand to increase amid efforts to control drug prices.
. (Read More)
Topic:
World
The Huffington Post | Full News Feed:
MARIETTA, Pa. — Malaria. Tuberculosis. Alzheimer's disease. AIDS. Pandemic flu. Genital herpes. Urinary tract infections. Grass allergies. Traveler's diarrhea. You name it, the pharmaceutical industry is working on a vaccine (Read More)
Add something
|
|
|
|
|
